Abstract Background: The field of interventional cardiology continues to rapidly evolve as a result of many advances in devices as well as adjunctive medications which have been paralleled by a concomitant improvement in the safety and efficacy of PCI. Objectives: We aimed at registering our elective PCI procedures with respect to their procedure details, outcome, in hospital complications and long term follow up. We tried to determine our performance in comparison to other registries and to find out risk factors associated with poor outcome. Patient and methods: The material of this study included 1897 patients (1564 males and 333 females) who underwent PCI at the Critical Care Department, Cairo University between January 2003 to December 2007 with a follow up of 1-5 years. Retrospective analysis of those data had been done including clinical events such as death, MI, target vessel revascularization (TVR) and major adverse cardiac events (MACE). Results: The cohort was predominantly male (82.2%) with a mean age of 55 ± 9 years. We had wide variety of PCI procedures, BMS stenting shared up 75.1% of our patients, DES 9.8%, PTCA 4.1%, failed PCI 4.4%, combined stents 1.2% and stenting with PTCA contributed 5.4% of the * Corresponding author. E-mail address: ayman186@hotmail.com (A. El Nagger). Conclusion: Our experience is comparable to other registries. We differed in our demographic features which affected our patient's characteristics. However, we need to establish our own registries based on our real life scenarios in the developing countries.
Introduction
Large-scale multicenter data collection efforts have been used to evaluate cardiovascular procedures. [1] [2] [3] [4] This work has been limited somewhat either geographically or by institutional selection. Furthermore, the data elements collected and their definitions have varied.
The American College of Cardiology (ACC) established the National Cardiovascular Data Registry (ACC-NCDR) to provide a uniform and geographically comprehensive view of cardiovascular procedures across the Untied State of America. A total of 139 hospitals submitted data on 100, 292 procedures and were included in their analysis set. 5, 6 The Melbourne Interventional Group (MIG) also is a voluntary collaboration of interventional cardiologists, at eight hospitals (seven public and one private) in Australia (Victoria region). Members of the group contributed data on consecutive patients (undergoing PCI between April 2004 to August 2007), to a central registry. The aim of their study was to analyze demographic, clinical and procedural characteristics of their PCI population and to report on 30-day and 12-month clinical outcomes in eligible patients. 7 The European Society of Cardiology (ESC) has adopted the Euro Heart Survey program, to evaluate to which extent clinical practice endorses existing guidelines as well as to identify differences in population profiles, patient management, and outcome across Europe. The survey on coronary revascularization was conducted between November 2001 and March 2002 with 1 year follow up. They reported 4770 patients with median follow up period of 12 months (11-13 months). 8 The NCVD is an initiative under the Malaysian Ministry of Health (MOH) that collects information about cardiovascular disease. A total of 2349 PCI cases in 1249 patients was enrolled in the first 6 months of 2007. The NCVD database was established to integrate these various databases and other data sources to achieve a nation-wide database. 9 National PCI registry was held in Thailand (NR-Th) to determine safety and efficacy of PCI in Thailand. It began on May 2006 and it recruited 4146 PCI procedures which were performed in 27 participating sites. 10 The aim of this study was to analyze demographic, clinical and procedural characteristics of our PCI population and to report on in hospital complications and clinical outcome with 5 years follow up. We also aimed to benchmark our registry with other national PCI registries which would facilitate future research and development.
Material and methods
The Egyptian Critical Care Department Angioplasty Registry (ECDAR) is a single-center PCI registry, where admitted patients for PCI were included in the database. The standardized data abstraction form and dataset definitions were designed in the light of the Cardiology Audit and Registration Data Standards (CARDS) project. The case report forms (CRFs) were designed to collect detailed demographic, past medical history, clinical and procedural information.
Patients who underwent elective PCI at Critical Care Department, Cairo University Hospitals, were enrolled. Data recording was designed for PCI procedures through the period, from 1st January 2003 till 31st December 2007.
We examined 1897 consecutive PCI procedures between January 2003 and December 2007. We reported demographic, clinical and procedural characteristics of the total PCI population enrolled during this period and clinical outcomes for inhospital stay and every 12-month follow up.
The interventional strategy and stent selection were left to the discretion of the operator in all procedures. Total stent length was used as a surrogate measure for target lesion length, and stent diameter for target vessel diameter.
In hospital complications were recorded at the time of hospital discharge. All cardiac events were documented, including death, myocardial infarction (MI), target vessel revascularization (TVR), and composite major adverse cardiac events (MACE), comprising death, MI and TVR.
Ethical approval for our study was obtained from the Cairo University Hospitals Research Ethics Committee (ERC).
Continuous variables were summarized as means and SDs. Categorical data were summarized as percentages. Univariate and multivariate analysis models were used to test for the preferential effect of all important variable(s) on occurrence of complications. All statistical calculations were done using computer programs Microsoft Excel 2007 (Microsoft Corporation, NY, USA) and SPSS (Statistical Package for Social Science).
Results

Baseline patients characteristics
As shown in Table 1 , our study is a non-controlled retrospective study involving 1897 patients who were subjected to elective PCI in the Critical Care Department during the period from 2003 to 2007. It included 1564 males (82.4%) and 333 females (17.6%) with a mean age of 54.7 ± 9.4 years. Age group (40-60 years old) constituted 68.8%, patients younger than 40 years constituted 8.7% and patients older than 60 years old constituted 22.5% of all patients.
Smoking was the most common risk factor (74.8%) and 37.4% of our patients were diabetic.
Over viewing our PCI indication, unstable angina was the most common indication (61.4%) while NSTEMI was the least common indication to undergo PCI (1%). Sixty-seven patients (3.8%) had manifestations of congestive heart failure with low EF, 20 (1.1%) patients had an identified renal impairment, 16 (0.9%) patients had peripheral vascular disease and seven (0.4%) patients had previous cerebrovascular event.
Angiographic data
As shown in Table 2 , the prevalence of single vessel disease was present in 1183 patients (62.4%), two vessels disease was evident in 575 patients (30.3%) and multi-vessel disease (MVD) was noticed in 139 patients (7.1%). It was noted that 162 patients (8.5%) had previous coronary stenting within 2 years after their first PCI and 55 patients (2.9%) were considered post CABG status.
There were 2831 vessels with 3172 affected segments with more than 50% stenosis according to Syntax score. Not all lesions were subjected to PCI trial. Untreated segments were either of small caliber or located in the distal vessels. LAD has the highest frequency (57.3%), RCA involvement was seen in 22.1%, while LCX involvement was present in 19.4% of our patients and left main was present in 1.2% of cases.
The most intervened segment was proximal LAD (36.8%) followed by Mid LAD (18.2%) and proximal RCA (15%).
Upon revising treated lesions, average lesion length was 16 ± 5 mm (range from 6 to 36 mm) and average stenosis percentage before PCI was 86 ± 10%. Type B was the most prevalent ACC/AHA morphology pattern (42.2%).
PCI procedures and complications data
As shown in Table 3 , BMS stenting was done in 75.1%, DES in 9.8% and PTCA in 4.1% of our patients, 21 patients (1.2%) had both BMS and DES and 103 patients (5.4%) had both stenting and PTCA. Angiographic success had been achieved in 95.5% and failed PCI was reported in 4.4% which might be attributed in 69% of cases due to failure of crossing by the guide wire. About 84.7% of treated vessels were exclusively stented with average stent length of 21 ± 5 mm and stent diameter of 3 ± 0.25 mm. The procedural complications including the acute stent occlusion occurred in 2.2% of cases, side branch occlusion was noticed in 2.5% of patients, distal embolization in 0.9% and coronary dissection in 1.1% of patients.
3.4. Clinical success of PCI procedure: Table 3 Clinical success was achieved in 94.2% of cases. It was defined as accomplishing PCI procedure with no in hospital MACE, a major bleeding, new or worsening renal impairment or cerebrovascular event. In hospital death event was reported in 0.3% in our series and MI in 0.5% with no TVR event was reported in our series.
Follow up data
In our registry, 1362 patients could be followed up (71.8%). Average follow up was 2.5 ± 1.3 years (range 1-5 years). Follow up was done on phone basis (71.3%) and through clinical follow up (28.7%). MACE rate differed significantly among stent and PTCA groups (23.3% in stent group vs. 43.1% in PTCA group <0.003). Death rate was 3.2% of first year and increased up to 24.2% after 5 years (Fig. 1) . MI rate was 2.1% at 1 year increased up to 17.2% at 5 years follow up (Fig. 2) . TVR was recorded in 8% at 1 year, increased up to 35.9% at 5 years follow up (Fig. 3) . MACE was 10.1% at 1 year and reached 57.2% at 5 years follow up (Fig. 4) .
Risk factors for poor outcome
As shown in Table 4 , there was a significant relationship between renal impairment, complete total occlusion (CTO), lesion length >20 mm and bifurcation lesions and occurrence of PCI complications (25% vs. 6.6%, P < 0.002; 9.7% vs. 6%, Figure 1 Death rate through the follow up period of the study. P < 0.01; 12% vs. 5.1%, P < 0.002 and 14.4% vs. 6.3%, P < 0.01, respectively). Post dilatation was done in 329 patients (17.3%) and has been associated with less complications' rates (2.4% vs. 7.8%, P < 0.002), respectively. In addition, increasing the number of deployed stents was associated with higher incidence of complications (5.9% for stent, 7.1% for 2 stents and 28% for 3 stents).
Discussion
PCI registries are able to longitudinally track patient outcomes in relation to baseline patient characteristics, indications for intervention, coronary anatomy and procedural technique. PCI registries could detect trends towards adverse outcomes and variations in PCI use that may warrant re-assessment of its use in specific circumstances and facilitate monitoring and benchmarking of PCI performance.
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PCI registries varied in their patient populations, regarding age, sex and other associated medical conditions. Also PCI indications varied among different PCI registries. Our registry included significantly smaller number of patients, with the exception of NCVD (P value <0.001). Our patients were also younger (55 ± 9 years) in comparison to these registries, except for NCVD where their patients were an average age of 56 years old. [6] [7] [8] [9] [10] Gender composition was significantly different in our registry than in other registries. Females represented 17.8% of our total population, which was close to females' contribution in NCVD registry (18% of their enrolled patients). Females in our registry were less than in other registries where females represented 25-34% of their patient's populations (P value <0.001). [6] [7] [8] [9] [10] Smoking was the most common risk factor for IHD in our registry (74.8% of our patients). It has significantly lower prevalence than in other studies (P value <0.001).
6-10 Also 37.4% of our patients were diabetic, this was higher than in ACC-NCDR, MIG and ESC registries (P value <0.001). Diabetes was present at a higher prevalence in NCVD registry (P value <0.003). Our registry and Thailand registry had close diabetes prevalence (37.4% vs. 37.7%). Diabetes prevalence varied among developed and developing countries. In developed countries, diabetes ranged between 23% and 36% while in developing countries; diabetes ranged between 37% and 43%. [6] [7] [8] [9] [10] Unstable angina was the most prominent indication in our study to undergo PCI (61.4%), which was close to ACC-NCDR (62%). Unstable angina was more in our registry than that in MIG and MCVD (14.9-26.3%) P value <0.001. [6] [7] [8] [9] [10] In our study previous cardiac intervention was lower in our registry in general, where it was 8.3% for previous PCI procedures and 2.8% for CABG surgeries which was less than that reported in other registries (29-35%), P value <0.001. This difference is attributed for availability of medical care facilities and medical awareness. [6] [7] [8] [9] [10] Congestive heart failure manifestations were present in 3.8%, similar to MIG results. 6, 7 Renal functions impairment was present to a lesser extent in our study (1.1%) while it ranged from 3.6% to 6.7% in other studies (P value <0.001). [6] [7] [8] [9] [10] Cerebrovascular disorders were present in 0.4% of patients in our registry. This was much less than that reported in MIG and ESC registries (5.6-6%, P < 0.001). Peripheral vascular disease (PVD) was present in 0.9% in our study and also it was present much less in our registry, compared to MIG, ESC and ACC-NCDR registries (6.7-12.1%; P < 0.001). [6] [7] [8] The low prevalence of renal impairment, CHF and PVD in our registry could be attributed to the lower age of our patients.
The extent of complex coronary artery disease in our patients is less than in other studies, P value <0.001). Single vessel disease accounted for 62.4% in our study, while it accounted for 35.2-45% in other studies. Our study had less MVD prevalence (7.1%) in comparison to other registries where MVD accounted for 21-58.1% in other studies. Also, number of vessels to be treated differed between our study and other studies. [6] [7] [8] [9] [10] For ACC/AHA lesion morphology classification, our patients had simpler lesions than in other registries. 7, 8 Stenting was performed in 90.9% of patients enrolled in our study while it was performed much less in ACC-NCDR and ESC registries (71-75%, P value <0.001). We had PTCA done in 4.4% of cases, while PTCA contributed to 19% in ACC-NCDR registry and in 11.8% in Thailand registry, P value <0.001. [6] [7] [8] [9] [10] Angiographic success was achieved in 95.5% in our series. This was also echoed in other registries. Failed PCI constituted 4.4% of our PCI procedures which was comparable to that encountered in ACC-NCDR registry (4.4% vs. 5.5%). 6 Clinical success was achieved in 94.2% in our series which was close to that achieved in ACC-NCDR registry (92.2%) and higher than that achieved in the Thailand registry (94.2% vs. 90.1%). Our results are close to results of other registries, concerning procedural complications. Our in hospital MACE or follow up MACE were less reported than in other registries. [6] [7] [8] [9] [10] In our registry, 1362 patients were followed up (71.8%). Average follow up time was 2.5 ± 1.3 years (range 1-5 years). Our lower incidence of follow up MACE may be attributed to lower age of our patients with less complex CAD anatomy. Besides, our registry was based on elective PCI procedures, while other registries were based on elective and urgent intervention, e.g., primary PCI procedures with higher complications' rates. [6] [7] [8] [9] [10] Through reviewing our patients' database, we could confirm a significant relationship between renal impairment and occurrence of PCI procedure complications. This finding was confirmed by other authors and considered a risk factor for PCI morbidity and renal impairment has been incriminated in risk estimation model. [12] [13] [14] We tried to determine other risk factors associated with poor outcome in our study group. Chronic total occlusion (CTO), long lesions, i.e., >20 mm and bifurcational lesions were significantly related to poor outcomes in our patients.
In patients with CTO lesions, complication rate was 9.7% vs. those with non-CTO who had a complication rate of 6% (P value: 0.018). In another study chronic total occlusions are known to carry worse prognosis as compared to non-CTO lesion. 15 Through reviewing our angiographic data, patients with lesion length >20 mm had a complications' rate of 12%. The length has been incorporated in angiographic determinants of adverse outcomes after PCI. 16 Patients with bifurcational lesions had a higher complications' rate than those with non bifurcational lesions (14.4% vs. 6.3%, P value <0.011). This was supported by many studies that showed higher incidence of complications with bifurcation lesion. 17 Post dilatation had been associated with less complication rates (2.4% vs. 7.8%, P value <0.002). Many authors confirmed such findings. 18 Regarding the number of stents and incidence of complication it was found that three stents have been associated with a higher complications' rate than one or two stents and mutli-vessel PCI poses more challenge to angiographies and increases the burden of PCI outcomes. 19 We analyzed also our follow up data and concluded that certain risk factors are related to the incidence of MACE. Stenting vs. PTCA and Syntax score are related to MACE occurrence in our series. Stenting had significantly less MACE rate than PTCA (25% vs. 44.2%, P value <0.016). This was confirmed through many studies. 20 Patients with low Syntax scores has significantly less MACE rates than patients with intermediate or high Syntax scores (20.2% vs. 90.4%, P value <0.001). Syntax score has been incorporated in choice of revascularization strategies. 21 
Conclusion
Through reviewing and comparing our data, we concluded that our experience is comparable to other registries. We differed in our demographic features which affected our patient's characteristics. These findings were echoed in other developing countries like Malaysia and Thailand.
This confirmed our need to establish our own registries, based on our real life scenarios in developing countries where patients' demographics differ significantly, despite close results which might not be true on larger scale studies.
However, despite the significant difference in patients' characteristics (e.g. age, sex and risk factors for CAD) and complexity of our lesions, our results were quite close to results of other registries in short and long term follow up aspects (procedural complications and our follow up MACE).
This study sheds different light from a different perspective on the practice of cardiovascular intervention. Percutaneous coronary intervention procedure differs from one country to another regarding patient selection, elective vs. emergent procedures, availability of medical care facilities, medical awareness, financial restriction and operators' preference in selecting treatment strategies. This may lead to different results reflecting the special nature of each registry.
